Menu
Novel monoclonal antibody development in just 40-60 days! Precision Antibody uses its proprietary procedures and platform to rapidly generate application specific monoclonal antibodies (mAbs). Precision Antibody customizes project strategies to ensure the delivery of mAbs that work in the intended applications.
Precision Antibody has developed numerous antibodies for:
At times you may encounter the situation “I needed that antibody, yesterday!!” Well, PA cannot reverse the time to accommodate your needs, but we offer the next best option and develop high-affinity hyperimmune serum in less than 3 weeks using mice or rats. Affinity purification will add additional 7-10 days. The development of rat polyclonal antibody is the most popular option for many of our customers. Due to the high specific IgG titer we achieve, even a smaller amount of serum goes a long way in your research.
PA offers traditional rabbit polyclonal antibody development service. We have 60 or 90-day protocols and continuous production of antibody is possible.We also offer antibody purification services from rabbit polyclonal serum. (see Antibody Production and Purification section)
Please contact our specialist for rabbit polyclonal service.
For immunization of larger animals, please inquire.
PA offers fully human antibody development using transgenic mice. Precision Antibody uses its proprietary procedures and platform to rapidly generate specific therapeutic monoclonal antibodies. We are capable to developing a large number of antigen-specific clones producing fully human IgG in about 60 days. Please inquire.
Precision Antibody™ has been providing comprehensive service for high quality rapid antibody development to pharmaceutical, biotech, academic and federal laboratory customers for over 20 years.
There are many companies offering seemingly similar services at varying cost. Developing antibodies against your antigen is one thing. However, developing antibodies that work in your intended application is entirely different. Many budget service may deliver a limited number of hybridoma clones producing monoclonal antibodies that recognize the antigen in a solid phase ELISA assay or in a Western blot but there is no guarantee that the developed antibodies will work in your intended applications. Our success rate in the delivery of antibodies that work in your intended assay is >95 %. The industry average is less than 50%.
Precision Antibody™ develops hyper immune serum titer (>1:100,000) suitable for hybridoma development in about 20 days.
Every antibody development project is unique and understanding of biology behind each project is important. Scientists at Precision Antibody have vast scientific background in immunology, cancer, cell, developmental, and molecular biology, and biochemistry. Your project starts with in-depth discussion with detailed attention to your needs between the Principal Investigator (PI) and our scientists. Particular attention will be given to your intended assay so that we can help you choose appropriate immunogen and screening strategies. We will provide a quote based on the discussion. If you choose to go forward, we will provide a project specification that covers the project, as necessary.
Scientists at our Research and Development (R&D) department are continually improving our state-of-the-art proprietary technology to achieve cost effective development of quality antibodies to serve you better.
All of the development processes are performed at our Columbia, Maryland facility, and we do not out-source our work outside the United States as many of our competitors offering budget price do. Your work remains confidential and all the products we generate belong to you. We are AAALAC and OLAW accredited.
Our Precision Antibody™ team has developed custom monoclonal antibodies used for many applications such as:
We are the preferred service provider for major global pharmaceutical and biotechnology companies. We also provide BPA for NIH researchers. We are recognized by government agencies as quality antibody developer that provides comprehensive service as evident from our track record for being selected as antibody development contractor for the following initiatives:
We have five milestone-based phases and phase-based pricing to help our clients as we move along the project. All the processes we perform within the phase are clearly defined. At each phase, we provide data so that our clients can make informed decision to move forward thereby minimizing their risk. Good communication throughout the course of the project is an essential part leading to a successful completion of the project.
We can send 3-5 ml culture supernatants collected from hybridoma clones producing monoclonal antibodies against the target antigen to our customers for validation in their assay if required.
Clones chosen by the validation process will be expanded, cryopreserved, and delivered.
40 to 60 days.
Most antibody developers feel that developing one ELISA-positive antibody recognizing your antigen is sufficient. At Precision Antibody™, we strive to develop antibodies that meet your specific application needs. Our success rate in delivering clones that work in our clients’ application is over 95%
All the clones developed are yours. Precision Antibody does not retain any ownership. We are happy to exchange CDA, NDA, & MSA.
We understand the budget restrains you may have. We offer various antibody development programs to accommodate your budgetary restrictions. Please contact us for additional information.
All clones developed are the customer’s property.
Precision Antibody does not retain any ownership.
We are happy to exchange CDA, NDA, & MSA.
We pride ourselves on our customer service!
